Hamed I. Ali

Employment

• Texas A&M University
  2013 - Present

Education

• Okayama University Ph.D.
  2003 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (91)

• Rutin as promising drug for the treatment of Parkinson’s disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies
  Molecular Simulation 2019 DOI: 10.1080/08927022.2019.1662003
  +Save
• Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds
  Bioorganic and Medicinal Chemistry 2019 DOI: 10.1016/j.bmc.2019.02.027
  +Save
• Targeting CDC7 sensitizes resistance melanoma cells to BRAFV600E-specific inhibitor by blocking the CDC7/MCM2-7 pathway
  Scientific Reports 2019 DOI: 10.1038/s41598-019-50732-w
  +Save
• Abstract B41: Transcriptome-wide profiling identifies novel differential genes associated with health disparity of prostate cancer
  2018
  +Save
• Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients
  Scientific Reports 2018 DOI: 10.1038/s41598-018-34637-8
  +Save
• LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor
  Scientific Reports 2018 DOI: 10.1038/s41598-018-19790-4
  +Save
• Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
  European journal of medicinal chemistry 2018
  +Save
• Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
  European Journal of Medicinal Chemistry 2018 DOI: 10.1016/j.ejmech.2017.12.023
  +Save
• Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition
  European Journal of Medicinal Chemistry 2018 DOI: 10.1016/j.ejmech.2018.04.029
  +Save
• Synthesis and molecular docking study of new benzofuran and furo [3, 2-g] chromone-based cytotoxic agents against breast cancer and p38$α$ MAP kinase inhibitors
  Bioorganic chemistry 2018
  +Save